Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Open Phase I Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002 in Patients With Advanced Solid Tumors

NCT06832982 is registered in ClinicalTrials.gov with Shanghai Pushi Medical Science Co. Ltd as lead sponsor.

NCT NCT06832982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06832982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Open Phase I Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002 in Patients With Advanced Solid Tumors
Lead sponsor
Shanghai Pushi Medical Science Co. Ltd
Phase
Phase 1
Overall status
Recruiting
Start date
February 24, 2025
Completion date
February 19, 2028
Enrollment
66 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors